Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
- DOI
- 10.5812/hepatmon.35339
- Published
- 2016 May
- Container
- Hepatitis monthly
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5812/hepatmon.35339,
title = {Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?},
author = {Dabbous HM and Montasser IF and Sakr MA and Refai R and Sayam M and Abdelmonem A and Sayed H and F Abdelghafar M and Bahaa M and S Elmeteini M},
year = {2016},
journal = {Hepatitis monthly},
doi = {10.5812/hepatmon.35339},
url = {https://doi.org/10.5812/hepatmon.35339}
}RIS
TY - JOUR TI - Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far? AU - Dabbous HM AU - Montasser IF AU - Sakr MA AU - Refai R AU - Sayam M AU - Abdelmonem A AU - Sayed H AU - F Abdelghafar M AU - Bahaa M AU - S Elmeteini M PY - 2016 JO - Hepatitis monthly DO - 10.5812/hepatmon.35339 UR - https://doi.org/10.5812/hepatmon.35339 ER -
APA
HM, D., IF, M., MA, S., R, R., M, S., A, A., H, S., M, F. A., M, B., & M, S. E. (2016). Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?. Hepatitis monthly. https://doi.org/10.5812/hepatmon.35339
Source records
- pubmed · retrieved 2026-09-25T01:43:55.667Z